The Efficacy of Combining EGFR Monoclonal Antibody With Chemotherapy for Patients With Advanced Nonsmall Cell Lung Cancer: A Meta-Analysis From 9 Randomized Controlled Trials

Although epidermal growth factor receptor (EGFR) monoclonal antibodies (mAbs) have been proved synergistic effect when combined with cytotoxic agents for advanced nonsmall cell lung cancer (NSCLC), the results of relevant clinical trials remain controversial. The purpose of this meta-analysis was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Jin, Yang, Yun-Peng, Zhao, Yuan-Yuan, Qin, Tao, Hu, Zhi-Huang, Zhou, Ting, Zhang, Ya-Xiong, Hong, Shao-Dong, Ma, Yu-Xiang, Zhao, Hong-Yun, Huang, Yan, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602912/
https://www.ncbi.nlm.nih.gov/pubmed/26313787
http://dx.doi.org/10.1097/MD.0000000000001400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602912/
https://www.ncbi.nlm.nih.gov/pubmed/26313787
http://dx.doi.org/10.1097/MD.0000000000001400

Ejemplares similares